HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Clinical features and long-term outcome of nephrotic syndrome associated with heterozygous NPHS1 and NPHS2 mutations.

AbstractBACKGROUND AND OBJECTIVES:
Mutations in nephrin (NPHS1) and podocin (NPHS2) genes represent a major cause of idiopathic nephrotic syndrome (NS) in children. It is not yet clear whether the presence of a single mutation acts as a modifier of the clinical course of NS.
DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS:
We reviewed the clinical features of 40 patients with NS associated with heterozygous mutations or variants in NPHS1 (n = 7) or NPHS2 (n = 33). Long-term renal survival probabilities were compared with those of a concurrent cohort with idiopathic NS.
RESULTS:
Patients with a single mutation in NPHS1 received a diagnosis before those with potentially nongenetic NS and had a good response to therapies. Renal function was normal in all cases. For NPHS2, six patients had single heterozygous mutations, six had a p.P20L variant, and 21 had a p.R229Q variant. Age at diagnosis and the response to drugs were comparable in all NS subgroups. Overall, they had similar renal survival probabilities as non-NPHS1/NPHS2 cases (log-rank chi(2) 0.84, P = 0.656) that decreased in presence of resistance to therapy (P < 0.001) and in cases with renal lesions of glomerulosclerosis and IgM deposition (P < 0.001). Cox regression confirmed that the only significant predictor of dialysis was resistance to therapy.
CONCLUSIONS:
Our data indicate that single mutation or variant in NPHS1 and NPHS2 does not modify the outcome of primary NS. These patients should be treated following consolidated schemes and have good chances for a good long-term outcome.
AuthorsGianluca Caridi, Maddalena Gigante, Pietro Ravani, Antonella Trivelli, Giancarlo Barbano, Francesco Scolari, Monica Dagnino, Luisa Murer, Corrado Murtas, Alberto Edefonti, Landino Allegri, Alessandro Amore, Rosanna Coppo, Francesco Emma, Tommaso De Palo, Rosa Penza, Loreto Gesualdo, Gian Marco Ghiggeri
JournalClinical journal of the American Society of Nephrology : CJASN (Clin J Am Soc Nephrol) Vol. 4 Issue 6 Pg. 1065-72 (Jun 2009) ISSN: 1555-905X [Electronic] United States
PMID19406966 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Intracellular Signaling Peptides and Proteins
  • Membrane Proteins
  • NPHS2 protein
  • nephrin
Topics
  • Adolescent
  • Child
  • Child, Preschool
  • Female
  • Follow-Up Studies
  • Genetic Variation
  • Heterozygote
  • Humans
  • Infant
  • Intracellular Signaling Peptides and Proteins (genetics)
  • Kaplan-Meier Estimate
  • Male
  • Membrane Proteins (genetics)
  • Nephrotic Syndrome (genetics, mortality)
  • Point Mutation

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: